| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS | 46.249.452 kr. | 25. oktober 2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Glenmark Pharmaceuticals Nordic AB, Teva Denmark A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Macure Pharma ApS, Macure Pharma ApS, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Orifarm A/S | 284.601.687 kr. | 25. oktober 2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Glenmark Pharmaceuticals Nordic AB, Teva Denmark A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Macure Pharma ApS, Macure Pharma ApS, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Orifarm A/S | 284.601.687 kr. | 25. oktober 2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Glenmark Pharmaceuticals Nordic AB, Teva Denmark A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Macure Pharma ApS, Macure Pharma ApS, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Orifarm A/S | 284.601.687 kr. | 25. oktober 2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Glenmark Pharmaceuticals Nordic AB, Teva Denmark A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Macure Pharma ApS, Macure Pharma ApS, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Orifarm A/S | 284.601.687 kr. | 25. oktober 2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Glenmark Pharmaceuticals Nordic AB, Teva Denmark A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Macure Pharma ApS, Macure Pharma ApS, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Orifarm A/S | 284.601.687 kr. | 25. oktober 2026 |
| Amgros 2027 1.618.b | Amgros I/S | Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Aspen Pharma Ireland Limited, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S | 32.174.840 kr. | 21. oktober 2026 |
| Amgros 2027 1.618.b | Amgros I/S | Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Aspen Pharma Ireland Limited, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S | 32.174.840 kr. | 21. oktober 2026 |
| Amgros 2027 1.618.b | Amgros I/S | Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Aspen Pharma Ireland Limited, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S | 32.174.840 kr. | 21. oktober 2026 |
| Amgros 2027 1.618.b | Amgros I/S | Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Aspen Pharma Ireland Limited, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S | 32.174.840 kr. | 21. oktober 2026 |
| Amgros 2027 1.618.b | Amgros I/S | Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Aspen Pharma Ireland Limited, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S | 32.174.840 kr. | 21. oktober 2026 |
| Amgros 2027 1.618.b | Amgros I/S | Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Aspen Pharma Ireland Limited, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S, Abacus Medicine A/S, Takeda Pharma A/S | 32.174.840 kr. | 21. oktober 2026 |
| Amgros 2027 1.606.b | Amgros I/S | Abcur AB, Orifarm A/S, Abacus Medicine A/S, Abcur AB, Orifarm A/S, Abacus Medicine A/S, Abcur AB, Orifarm A/S, Abacus Medicine A/S | 101.000.000 kr. | 21. oktober 2026 |
| Amgros 2027 1.606.b | Amgros I/S | Abcur AB, Orifarm A/S, Abacus Medicine A/S, Abcur AB, Orifarm A/S, Abacus Medicine A/S, Abcur AB, Orifarm A/S, Abacus Medicine A/S | 101.000.000 kr. | 21. oktober 2026 |
| Amgros 2027 1.606.b | Amgros I/S | Abcur AB, Orifarm A/S, Abacus Medicine A/S, Abcur AB, Orifarm A/S, Abacus Medicine A/S, Abcur AB, Orifarm A/S, Abacus Medicine A/S | 101.000.000 kr. | 21. oktober 2026 |
| Amgros 2027 1.601.a | Amgros I/S | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S | 75.178.698 kr. | 20. oktober 2026 |
| Amgros 2027 1.601.a | Amgros I/S | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S | 75.178.698 kr. | 20. oktober 2026 |
| Amgros 2027 1.601.a | Amgros I/S | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S | 75.178.698 kr. | 20. oktober 2026 |
| Amgros 2027 1.601.a | Amgros I/S | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S | 75.178.698 kr. | 20. oktober 2026 |
| Amgros 2027 2.213.a | Amgros I/S | Orifarm A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Abacus Medicine A/S, Boehringer Ingelheim Danmark A/S, Chiesi Pharma AB, Chiesi Pharma AB, AstraZeneca A/S, Boehringer Ingelheim Danmark A/S | 44.368.590 kr. | 13. oktober 2026 |
| Amgros 2027 2.210.a | Amgros I/S | Teva Denmark A/S, Teva Denmark A/S, Abacus Medicine A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Teva Denmark A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Abacus Medicine A/S, Orifarm A/S, Orifarm A/S, Nordic Prime ApS | 51.724.677 kr. | 13. oktober 2026 |
| Amgros 2027 2.210.a | Amgros I/S | Teva Denmark A/S, Teva Denmark A/S, Abacus Medicine A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Teva Denmark A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Abacus Medicine A/S, Orifarm A/S, Orifarm A/S, Nordic Prime ApS | 51.724.677 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, 2care4 ApS, Chiesi Pharma AB, Orion Pharma A/S, Orion Pharma A/S, Paranova Danmark A/S, 2care4 ApS, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB | 33.641.330 kr. | 13. oktober 2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, 2care4 ApS, Chiesi Pharma AB, Orion Pharma A/S, Orion Pharma A/S, Paranova Danmark A/S, 2care4 ApS, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB | 33.641.330 kr. | 13. oktober 2026 |
| Amgros 2027 1.1203.a | Amgros I/S | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Hameln Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, Glenmark Pharmaceuticals Nordic AB, Øresund Pharma ApS, Sandoz A/S, Orifarm A/S, Paranova Danmark A/S, Vingmed A/S, Abacus Medicine A/S, Paranova Danmark A/S | 148.085.649 kr. | 13. oktober 2026 |
| Amgros 2027 1.202.a | Amgros I/S | 2care4 ApS, Abacus Medicine A/S, Teva Denmark A/S, Macure Pharma ApS | 33.940.957 kr. | 13. oktober 2026 |
| Amgros 2027 2.203.b | Amgros I/S | Pfizer ApS, Pfizer ApS, Abacus Medicine A/S, Pfizer ApS, 2care4 ApS, Abacus Medicine A/S, Orifarm A/S, Pfizer ApS, 2care4 ApS, Orifarm A/S, Abacus Medicine A/S | 26.699.999 kr. | 13. oktober 2026 |
| Amgros 2027 2.203.b | Amgros I/S | Pfizer ApS, Pfizer ApS, Abacus Medicine A/S, Pfizer ApS, 2care4 ApS, Abacus Medicine A/S, Orifarm A/S, Pfizer ApS, 2care4 ApS, Orifarm A/S, Abacus Medicine A/S | 26.699.999 kr. | 13. oktober 2026 |
| Amgros 2027 2.203.b | Amgros I/S | Pfizer ApS, Pfizer ApS, Abacus Medicine A/S, Pfizer ApS, 2care4 ApS, Abacus Medicine A/S, Orifarm A/S, Pfizer ApS, 2care4 ApS, Orifarm A/S, Abacus Medicine A/S | 26.699.999 kr. | 13. oktober 2026 |
| Amgros 2027 1.1052.b | Amgros I/S | Biocon Biologics Ireland Limited, Orion Pharma A/S, Pfizer ApS, Samsung Bioepis NL B.V., Accord Healthcare AB, Roche Pharmaceuticals A/S, Orifarm A/S, Abacus Medicine A/S, 2care4 ApS | 704.000.000 kr. | 21. september 2026 |
| Rammeaftale om køb af Livmarli (maralixibat) | Amgros I/S | Abacus Medicine A/S | 36.000.000 kr. | 6. september 2026 |
| Amgros 2026 1.164.a | Amgros I/S | Orifarm A/S, Abacus Medicine A/S | 3.222.720 kr. | 24. juni 2026 |
| Amgros 2026 1.162.b | Amgros I/S | Sandoz A/S, Pfizer ApS, Roche Pharmaceuticals A/S, Abacus Medicine A/S | 733.000.000 kr. | 24. juni 2026 |
| Amgros 2027 1.1462.a | Amgros I/S | Abacus Medicine A/S | 121.000.000 kr. | 22. juni 2026 |
| Amgros 2026 1.501.a | Amgros I/S | Sandoz A/S, Abacus Medicine A/S, Abacus Medicine A/S | 9.051.663 kr. | 11. juni 2026 |
| Amgros 2026 1.501.a | Amgros I/S | Sandoz A/S, Abacus Medicine A/S, Abacus Medicine A/S | 9.051.663 kr. | 11. juni 2026 |
| Rammeaftale om køb af Livmarli (maralixibat) | Amgros I/S | Abacus Medicine A/S | 36.000.000 kr. | 7. juni 2026 |